Dissolved and financials
CVR: 29150397
EUR -371,223
Gross profit
Net result: EUR -371,265
No current owners
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 20 August 2014
CVR · view overview
No headcount reported
Director role ended: NORDIC BIOTECH GENERAL PARTNER II ApS
CVR · 20/08/2014
View the full event history
NORDIC BIOTECH VENTURE FUND II K/S was a Danish company of the type Kommanditselskab based in København K, founded in 2005. The company has been dissolved on 20 August 2014. The company was registered under the industry Uoplyst. In 2013, the company reported a gross profit of EUR -371,223 and a net result of EUR -371,265 compared with EUR -10,911,718 the year before. Equity in the 2013 report amounted to EUR 350,155.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201301/01/2013 – 31/12/2013 | -371K EUR | -371K EUR | 372K EUR | 350K EUR | - | |
| 201201/01/2012 – 31/12/2012 | -10.9M EUR | -10.9M EUR | 741K EUR | 721K EUR | - |
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. NORDIC BIOTECH VENTURE FUND II K/S is registered in the Danish CVR register with the status Dissolved and ceased on 20 August 2014.
The CVR number of NORDIC BIOTECH VENTURE FUND II K/S is 29150397.
In 2013, NORDIC BIOTECH VENTURE FUND II K/S reported a gross profit of EUR -371,223.
NORDIC BIOTECH VENTURE FUND II K/S was founded on 25 October 2005.
NORDIC BIOTECH VENTURE FUND II K/S was registered under the industry Uoplyst (industry code 999999).
NORDIC BIOTECH VENTURE FUND II K/S was located at c/o NB Capital ApS, Østergade 24A 1. tv, 1100 København K.
As of August 20, 2014, JUT NR. 2180 A/S has stepped down as auditor of NORDIC BIOTECH VENTURE FUND II K/S.
As of August 20, 2014, NORDIC BIOTECH GENERAL PARTNER II ApS has stepped down as daglig ledelse of NORDIC BIOTECH VENTURE FUND II K/S.
NORDIC BIOTECH VENTURE FUND II K/S was dissolved on August 20, 2014.
NORDIC BIOTECH VENTURE FUND II K/S has published its annual report for 2013. Gross profit came to DKK -371,223, and the net result was DKK -371,265.
NORDIC BIOTECH VENTURE FUND II K/S has published its annual report for 2012. Gross profit came to DKK -10,909,650, and the net result was DKK -10,911,718.
As of July 10, 2012, JUT NR. 2180 A/S has been appointed auditor of NORDIC BIOTECH VENTURE FUND II K/S.
As of July 10, 2012, EY Danmark A/S has stepped down as auditor of NORDIC BIOTECH VENTURE FUND II K/S.
As of October 25, 2005, EY Danmark A/S has been appointed auditor of NORDIC BIOTECH VENTURE FUND II K/S.
As of October 25, 2005, NORDIC BIOTECH GENERAL PARTNER II ApS is registered as daglig ledelse of NORDIC BIOTECH VENTURE FUND II K/S.
NORDIC BIOTECH VENTURE FUND II K/S was founded on October 25, 2005.

Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.

Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.

Selskabets formål er at drive virksomhed med handel og produktion samt hermed beslægtet virksomhed.

Companies in the same industry and area